[{"address1": "20 Eastbourne Terrace", "city": "London", "zip": "W2 6LG", "country": "United Kingdom", "phone": "44 20 3325 0660", "website": "https://www.livanova.com", "industry": "Medical Devices", "sector": "Healthcare", "longBusinessSummary": "LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products. The Neuromodulation segment designs, develops, markets, and sells VNS Therapy System, an implantable pulse generator and connective lead that stimulates the vagus nerve; difficult-to-treat depression and drug-resistant epilepsy devices. The Advanced Circulatory Support segment develops, produces, and sells temporary life support products. It serves perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals, other medical institutions, and healthcare providers. The company sells its products through direct sales representatives and independent distributors. LivaNova PLC was incorporated in 2015 and is headquartered in London, the United Kingdom.", "fullTimeEmployees": 2900, "companyOfficers": [{"maxAge": 1, "name": "Mr. Alex  Shvartsburg", "age": 53, "title": "Chief Financial Officer", "yearBorn": 1970, "fiscalYear": 2023, "totalPay": 1202899, "exercisedValue": 0, "unexercisedValue": 48031}, {"maxAge": 1, "name": "Mr. Michael D. Hutchinson", "age": 52, "title": "Senior VP, Chief Legal Officer & Company Secretary", "yearBorn": 1971, "fiscalYear": 2023, "totalPay": 1092187, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Trui  Hebbelinck", "age": 50, "title": "Chief Human Resources Officer", "yearBorn": 1973, "fiscalYear": 2023, "totalPay": 895046, "exercisedValue": 0, "unexercisedValue": 76978}, {"maxAge": 1, "name": "Mr. Vladimir A. Makatsaria", "age": 50, "title": "CEO & Director", "yearBorn": 1973, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Lindsey  Little", "title": "Senior Director of Investor Relations", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Deanna  Wilke", "title": "Vice President of Corporate Communications", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Matthew Joseph Dodds III", "title": "Senior Vice President of Corporate Development & IT", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Paul R. Buckman", "age": 67, "title": "President of Advanced Circulatory Support & GM of Transcatheter Mitral Valve Replacement", "yearBorn": 1956, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Stephanie  Bolton", "age": 41, "title": "President of Global Epilepsy", "yearBorn": 1982, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ahmet  Tezel Ph.D.", "title": "Chief Innovation Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 3, "boardRisk": 1, "compensationRisk": 3, "shareHolderRightsRisk": 3, "overallRisk": 2, "governanceEpochDate": 1725148800, "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 2, "previousClose": 49.08, "open": 49.05, "dayLow": 46.86, "dayHigh": 49.05, "regularMarketPreviousClose": 49.08, "regularMarketOpen": 49.05, "regularMarketDayLow": 46.86, "regularMarketDayHigh": 49.05, "beta": 1.004, "forwardPE": 13.131285, "volume": 479751, "regularMarketVolume": 479751, "averageVolume": 772311, "averageVolume10days": 567140, "averageDailyVolume10Day": 567140, "bid": 46.96, "ask": 47.04, "bidSize": 100, "askSize": 100, "marketCap": 2552548864, "fiftyTwoWeekLow": 42.75, "fiftyTwoWeekHigh": 64.475, "priceToSalesTrailing12Months": 2.1100118, "fiftyDayAverage": 49.848, "twoHundredDayAverage": 52.325226, "currency": "USD", "enterpriseValue": 3013235968, "profitMargins": -0.013710001, "floatShares": 51330034, "sharesOutstanding": 54298000, "sharesShort": 2119983, "sharesShortPriorMonth": 2423896, "sharesShortPreviousMonthDate": 1721001600, "dateShortInterest": 1723680000, "sharesPercentSharesOut": 0.039, "heldPercentInsiders": 0.00333, "heldPercentInstitutions": 1.04977, "shortRatio": 2.66, "shortPercentOfFloat": 0.051799998, "bookValue": 22.885, "priceToBook": 2.054184, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1719705600, "earningsQuarterlyGrowth": 13.141, "netIncomeToCommon": -16589000, "trailingEps": -0.31, "forwardEps": 3.58, "pegRatio": -3.4, "enterpriseToRevenue": 2.491, "enterpriseToEbitda": 17.247, "exchange": "NMS", "quoteType": "EQUITY", "symbol": "LIVN", "underlyingSymbol": "LIVN", "shortName": "LivaNova PLC", "longName": "LivaNova PLC", "firstTradeDateEpochUtc": 1445261400, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "061a8c8c-b203-3fe1-ac5c-dcaa64a141fe", "gmtOffSetMilliseconds": -14400000, "currentPrice": 47.01, "targetHighPrice": 90.0, "targetLowPrice": 55.0, "targetMeanPrice": 70.67, "targetMedianPrice": 72.0, "recommendationMean": 2.0, "recommendationKey": "buy", "numberOfAnalystOpinions": 9, "totalCash": 329236992, "totalCashPerShare": 6.064, "ebitda": 174706000, "totalDebt": 677529024, "quickRatio": 1.75, "currentRatio": 3.455, "totalRevenue": 1209731968, "debtToEquity": 54.528, "revenuePerShare": 22.327, "returnOnAssets": 0.03343, "returnOnEquity": -0.013359999, "freeCashflow": 132386496, "operatingCashflow": 125431000, "earningsGrowth": 14.0, "revenueGrowth": 0.084, "grossMargins": 0.67950994, "ebitdaMargins": 0.14442, "operatingMargins": 0.13267, "financialCurrency": "USD", "trailingPegRatio": 0.4488, "__fetch_time": "2024-09-05"}]